BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $746,834 | +70.6% | 16,600 | +66.1% | 0.00% | +100.0% |
| Q4 2022 | $437,837 | +77.3% | 9,994 | +316.2% | 0.00% | 0.0% |
| Q3 2021 | $247,000 | -78.9% | 2,401 | -77.0% | 0.00% | -80.0% |
| Q4 2020 | $1,173,000 | -68.8% | 10,460 | -83.7% | 0.01% | -82.8% |
| Q1 2020 | $3,760,000 | -20.3% | 64,308 | +9.2% | 0.03% | -12.1% |
| Q4 2019 | $4,719,000 | +158.0% | 58,900 | +136.5% | 0.03% | +106.2% |
| Q3 2019 | $1,829,000 | +553.2% | 24,900 | +741.8% | 0.02% | +433.3% |
| Q2 2019 | $280,000 | +2.9% | 2,958 | -13.0% | 0.00% | 0.0% |
| Q1 2019 | $272,000 | -76.0% | 3,400 | -76.6% | 0.00% | -50.0% |
| Q3 2018 | $1,132,000 | -17.9% | 14,500 | -33.2% | 0.01% | -25.0% |
| Q2 2018 | $1,378,000 | +70.8% | 21,711 | +146.7% | 0.01% | +100.0% |
| Q1 2018 | $807,000 | +85.1% | 8,800 | -19.3% | 0.00% | +33.3% |
| Q1 2017 | $436,000 | +2080.0% | 10,900 | +990.0% | 0.00% | – |
| Q2 2016 | $20,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |